Skip to content
My WebMD Sign In, Sign Up

Uterine Fibroids Health Center

Font Size

Sales Halted for Uterine-Fibroid Surgery Device


WebMD News from HealthDay

May 1, 2014 -- Sales of a device used in surgery to remove uterine fibroids have been halted due to concerns that they may worsen a rare but deadly type of cancer, Johnson & Johnson said Tuesday.

The company noted that while worldwide sales, distribution and promotion of the device -- called a morcellator -- have been suspended, it will not be taken off the market, the Wall Street Journal reported.

J&J took the action after the U.S. Food and Drug Administration warned doctors on April 17 that using a morcellator to remove uterine fibroids risked worsening a type of cancer called uterine sarcoma.

The FDA said 1 in 350 women who undergo uterine fibroid surgery have undetected uterine sarcoma, WSJ reported.

An FDA advisory committee will meet this summer to more closely examine morcellator use during uterine fibroid surgery. In a letter to customers, J&J said it was awaiting input from the FDA and the medical community.

Today on WebMD

uterine fibroid illustration
Symptoms and treatments.
uterus and ovary
Is location in the uterus a factor?
 
doctor holding model of female reproductive system
Surgical options for fibroids.
pregnant woman
Can complications occur?
 
Period Cramping Your Style
Article
uterus and inlay of fibroids
Article
 
woman talking to doctor
Article
Comparing Birth Control Pill
Article
 
woman sitting on floor in pain
Article
woman looking at ultrasound
Article
 
Teenage girl with heat pad on stomach
Article
woman exercising
Article
 

WebMD Special Sections